Correction to: Therapeutic drug monitoring of oral targeted antineoplastic drugs (European Journal of Clinical Pharmacology, (2020), 10.1007/s00228-020-03014-8)

Anna Mueller-Schoell, Stefanie L. Groenland, Oliver Scherf-Clavel, Madelé van Dyk, Wilhelm Huisinga, Robin Michelet, Ulrich Jaehde, Neeltje Steeghs, Alwin D.R. Huitema, Charlotte Kloft

Research output: Contribution to journalComment/debate

Abstract

Due to an error during production, some in-text and most of the in-table citations were not correctly displayed in the original previous online version of the article and have now been corrected. The original article has been corrected.

Original languageEnglish
Number of pages1
JournalEuropean Journal of Clinical Pharmacology
Early online date15 Dec 2020
DOIs
Publication statusE-pub ahead of print - 15 Dec 2020

Keywords

  • Targeted antineoplastic drugs
  • Tyrosine kinase inhibitors
  • Therapeutic drug monitoring
  • Oral anticancer drugs
  • Personalised medicine

Fingerprint Dive into the research topics of 'Correction to: Therapeutic drug monitoring of oral targeted antineoplastic drugs (European Journal of Clinical Pharmacology, (2020), 10.1007/s00228-020-03014-8)'. Together they form a unique fingerprint.

Cite this